A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and Older

A Multicenter, Double-blind, Parallel Phase III Study

NCT02352584 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults

NCT03357263 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine)

NCT02249221 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Multicenter, Double-blind, Parallel, Non-inferiority, Phase III Study

NCT02658409 ·Status: UNKNOWN ·Phase: PHASE3

To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC3102C' Administered Intramuscularly in Healthy Adults

NCT01750814 ·Status: COMPLETED ·Phase: PHASE3

Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers

NCT01987011 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine

NCT01201902 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older

NCT01949090 ·Status: COMPLETED ·Phase: PHASE2

Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older

NCT00753272 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older

NCT02665871 ·Status: UNKNOWN ·Phase: PHASE1

Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers

NCT01389466 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old

NCT01730378 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older

NCT00760617 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older

NCT00765076 ·Status: COMPLETED ·Phase: PHASE3

Inactivated Influenza A/H5N1 Vaccine in the Elderly

NCT00230750 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age

NCT01934127 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults

NCT00951041 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years

NCT00771615 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

NCT01045564 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older

NCT02553343 ·Status: COMPLETED ·Phase: PHASE2

Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration.

NCT02067117 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity and Safety Study of Inactivated Split Influenza Vaccine' in Healthy Korean Male Subjects

NCT02111070 ·Status: COMPLETED ·Phase: PHASE1

Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor

NCT03590808 ·Status: COMPLETED ·Phase: NA

Evaluation of the Safety and Immunogenicity of a Sublingual Influenza Vaccine NSV0001 in Healthy Male Volunteers

NCT02955030 ·Status: COMPLETED ·Phase: PHASE1

A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults

NCT06431607 ·Status: COMPLETED ·Phase: PHASE2